. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab 280: E75-E82, 2001.-Endothelial cells (EC) metabolize L-arginine mainly by arginase, which exists as two distinct isoforms, arginase I and II. To understand the roles of arginase isoforms in EC arginine metabolism, bovine coronary venular EC were stably transfected with the Escherichia coli lacZ gene (lacZ-EC, control), rat arginase I cDNA (AI-EC), or mouse arginase II cDNA (AII-EC). Western blots and enzymatic assays confirmed high-level expression of arginase I in the cytosol of AI-EC and of arginase II in mitochondria of AII-EC. For determining arginine catabolism, EC were cultured for 24 h in DMEM containing 0.4 mM Larginine plus [1-14 C]arginine. Urea formation, which accounted for nearly all arginine consumption by these cells, was enhanced by 616 and 157% in AI-EC and AII-EC, respectively, compared with lacZ-EC. Arginine uptake was 31-33% greater in AI-EC and AII-EC than in lacZ-EC. Intracellular arginine content was 25 and 11% lower in AI-EC and AII-EC, respectively, compared with lacZ-EC. Basal nitric oxide (NO) production was reduced by 60% in AI-EC and by 47% in AII-EC. Glutamate and proline production from arginine increased by 164 and 928% in AI-EC and by 79 and 295% in AII-EC, respectively, compared with lacZ-EC. Intracellular content of putrescine and spermidine was increased by 275 and 53% in AI-EC and by 158 and 43% in AII-EC, respectively, compared with lacZ-EC. Our results indicate that arginase expression can modulate NO synthesis in bovine venular EC and that basal levels of arginase I and II are limiting for endothelial syntheses of polyamines, proline, and glutamate and may have important implications for wound healing, angiogenesis, and cardiovascular function.
polyamines, proline, and glutamate (13, 29, 36) . There are two distinct isoforms of mammalian arginase (arginase I and II), which are encoded by different genes and differ in molecular and immunological properties, tissue distribution, subcellular location, and regulation of expression (9, 19) . Arginase I (a cytosolic enzyme) is highly expressed in the liver and to a much lesser extent in a few other cell types, whereas expression of arginase II (a mitochondrial enzyme) is widespread (20, 25) . Intracellular compartmentation of arginases may have important implications for arginine metabolism in mammalian cells. For example, because of its colocalization with ornithine decarboxylase (ODC) in the cytosol, arginase I may preferentially direct ornithine to polyamine synthesis, whereas arginase II may preferentially direct ornithine to proline and glutamate production due to the colocalization of arginase II and ornithine aminotransferase (OAT) in mitochondria ( Fig. 1) .
Almost all mammalian cells contain one of the isoforms of nitric oxide (NO) synthase (NOS) that synthesizes NO and L-citrulline from L-arginine (11, 16) . Interestingly, both arginase and NOS use arginine as a common substrate, and thus arginase may play a role in regulating NO synthesis by modulating intracellular arginine availability (19, 26, 36) . This idea is supported by reports that inhibition of arginase activity results in enhanced NO production by inducible NOS (iNOS) in activated macrophages (6, 8, 28) , although conflicting findings have also been reported (4) . Although relatively little is known about the role of arginase in NO synthesis by constitutive NOS (cNOS), recent studies using arginase inhibitors suggest that endogenous arginase activity partially inhibits NO synthesis by cNOS isoforms (1, 3) .
Endothelial cells (EC) represent a good model for studying the metabolic roles of the arginases because of the following reasons: they express endothelial NOS (eNOS), a cNOS that is essential for the regulation of vascular tone and permeability (18) ; they express OAT (34) and therefore are potentially capable of synthesizing both proline and glutamate from arginine; and they also synthesize polyamines from ornithine (23) . Both arginase isoforms can be expressed by EC (2) , but the role(s) of arginase expression in endothelial arginine metabolism is unknown. Thus the objective of this study was to test the hypothesis that arginase activity may be a limiting or regulatory factor in endothelial syntheses of NO, proline, glutamate, or polyamines by analyzing the impact of elevated expression of arginase I or arginase II on arginine metabolism in bovine microvascular venular EC. Cell culture. Bovine coronary venular EC were isolated from coronary venules (15 m in diameter) using a bead perfusion technique, as previously described (24, 33) . EC were cultured at 37°C in complete DMEM (DMEM with 1 mM sodium pyruvate, 20 mM D-glucose, 2 mM L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, 0.25 g/ml amphotericin B, and 10 U/ml heparin) containing 10% dialyzed FBS. Cell lines were passaged by trypsinization in Ca 2ϩ -and Mg 2ϩ -free DPBS containing 0.25% trypsin and 0.02% EDTA.
MATERIALS AND METHODS

Materials
Vector construction. pEF1-rARGI, a mammalian expression plasmid for rat arginase I, was constructed by inserting the EcoR I-BsaA I 1194-bp coding region fragment of pARGr-2 (10) into the EcoR I/Pme I sites of the plasmid pEF1/Myc-His C (Invitrogen, San Diego, CA). pEF1-mARGII, a mammalian expression vector for mouse arginase II, was constructed by inserting the EcoR I-BstE II 1249-bp coding region fragment of mouse arginase II cDNA (25) into the EcoR I/BstE II sites of pEF1/Myc-His C expression vector. In these two constructs, no epitope tags were fused to the arginases. For control transfection, pEF1/Myc-His/lacZ (In- Fig. 1 . Arginine metabolism in mammalian cells. ASL, argininosuccinate lyase; Asp, aspartate; ASS, argininosuccinate synthase; BH 4 , tetrahydrobiopterin; DCAM, decarboxylated 5-adenosylmethionine; Glu, glutamate; MTA, methylthioadenosine; NO, nitric oxide; NOS, nitric oxide synthase; OAT, ornithine aminotransferase; P5CD, pyrroline-5-carboxylate dehydrogenase; P5CR, pyrroline-5-carboxylate reductase; ␣-KG, ␣-ketoglutarate. Adapted from Wu and Morris (36) .
vitrogen) was used to represent the expression of an unrelated exogenous protein.
Transfection of EC. Bovine coronary venular EC at passages 6-9 were transfected with pEF1-rARGI, pEF1-mARGII, or pEF1/Myc-His/lacZ using TransIT-LT2 Polyamine Transfection Reagent (PanVera, Madison, WI) according to the manufacturer's instructions. Stably transfected cells were selected with antibiotic G418 (600 g/ml) in complete DMEM and then were examined for expression of arginases I and II by Western blot analysis, as described below. Transfected cells were maintained in complete DMEM containing G418 (600 g/ml) and were used at passages 10-20. Western blot analysis of arginases I and II. Stably transfected cells were lysed in 0.1% Triton X-100 containing 2 mM Pefabloc, 2 g/ml pepstatin A, and 10 g/ml leupeptin. Western blot analysis for arginase I and II proteins was performed as described previously (20, 21) . Before use for immunoblots, arginase I or arginase II antibody was diluted 1:50,000 or 1:10,000, respectively, in a solution containing 1% nonfat dry milk, 1% BSA, 20 mM Tris ⅐ HCl (pH 7.6), 137 mM NaCl, 5 mM MgCl 2 , and 0.1% Tween 20. The secondary antibody was peroxidase-conjugated rabbit anti-chicken IgY (Jackson ImmunoResearch Laboratories, West Grove, PA), which was diluted 1:5,000 before use. Immunoblots were developed using the enhanced chemiluminescence kit (Amersham, Arlington Heights, IL) according to the manufacturer's instructions.
Arginase assay. Arginase activity was measured in the cytosolic and mitochondrial fractions of EC as described previously (34) . Briefly, cells were harvested by trypsinization and washed two times with 250 mM sucrose-1 mM EDTA-50 mM potassium phosphate buffer (pH 7.5; buffer A). Cells were homogenized in buffer A containing 2.5 mM dithiothreitol and protease inhibitors (5 g/ml phenylmethylsulfonyl fluoride, 5 g/ml aprotinin, 5 g/ml chymostatin, and 5 g/ml pepstatin; buffer B). The homogenates were centrifuged at 600 g and 4°C for 15 min, and the supernatants were centrifuged at 14,000 g and 4°C for 15 min to obtain cytosolic (supernatant fluid) and mitochondrial (pellet) fractions. The pellet was washed two times with buffer B and then was lysed by three cycles of freezing and thawing. For determining arginase activity, assay mixture consisted of 50 l of 30 mM arginine, 50 l of 100 mM MnCl 2 , and 50 l of enzyme preparations (0.05 and 0.1 mg cell protein) and was incubated at 37°C for 0, 10, or 20 min. The incubation was terminated with addition of 50 l of HClO 4 , and neutralized extracts were used for analysis of ornithine by HPLC. Arginase assay was linear with time and the amounts of protein used. Cytosolic or mitochondrial arginase activity was calculated on the basis of protein content in the cytosol or mitochondria used for the enzyme assay.
Determination of arginine metabolites. Transfected EC (4-5 ϫ 10 6 cells/6 ml) were rinsed with DPBS and then were cultured at 37°C for 24 h in complete DMEM containing G418 (600 g/ml), 2% dialyzed FBS, 2 mM L-glutamine, 20 mM D-glucose, and 0.4 mM L-arginine plus L-[1-14 C]arginine. Conditioned media were used for determining nitrite and nitrate (two major stable end products of NO oxidation) as well as urea and amino acids, whereas cells were used for determining intracellular content of amino acids and polyamines, as described below.
Nitrite in culture media was analyzed on the basis of its derivatization with 2,3-diaminonaphthalene to form 2,3-naphthotriazole as described by Misko et al. (17) , except that the product was analyzed by HPLC to improve sensitivity and specificity (12) . Briefly, 100 l of 1:3 diluted medium or NaNO 2 standards (0-500 pmol/ml; prepared in blank culture medium) were incubated for 10 min at room temperature with 10 l of 316 M 2,3-diaminonaphthalene (in 0.62 M HCl), followed by addition of 5 l of 2.8 M NaOH. 2,3-Naphthotriazole was separated on a 5-m C 8 column (150 ϫ 4.6 mm ID; Supelco, Bellefonte, PA) guarded by a 40-m C 18 column (50 ϫ 4.6 mm ID; Supelco) and eluted with 15 mM sodium phosphate buffer (pH 7.5) containing 50% methanol (flow rate 1.3 ml/min). Retention time of 2,3-naphthotriazole was 4.4 min. The fluorescence of 2,3-naphthotriazole was monitored with excitation at 375 nm and emission at 415 nm. Nitrate in culture media was also measured by this HPLC method after its conversion to nitrite by nitrate reductase (31). The detection limit for nitrite and nitrate by the HPLC method was 10 nM. Production of nitrite plus nitrate was calculated after subtracting blank values for culture media without cells.
For determining medium urea and amino acids, an aliquot (200 l) of the culture medium was acidified with 100 l of 1.5 M HClO 4 , and the solution was neutralized with 50 l of 2 M K 2 CO 3 . Neutralized extracts were used for 1) urea analysis by an enzymatic method involving urease and glutamate dehydrogenase (29) 14 C]arginine as previously described (30) . Net production of urea was calculated after subtracting blank values for culture media without cells. Arginine consumption was calculated on the basis of arginine disappearance from culture media after correction of blank values for culture media without cells.
For determining cellular amino acids and polyamines, EC seeded in culture dishes were rapidly washed three times with 10 ml ice-cold DPBS (within a total of 20 s) to remove extracellular metabolites. Cells (5 ϫ 10 6 ) were then lysed in 200 l of 1.5 M HClO 4 , and the solution was neutralized with 100 l of 2 M K 2 CO 3 . The neutralized extracts were used for determining amino acids and polyamines (putrescine, spermidine, and spermine) by HPLC methods, as previously described by Wu et al. (37) . In preliminary studies to determine the efficiency of the cell-washing procedure in removing medium amino acids and polyamines, [ 14 C]sucrose was added to cell cultures immediately before removal of the conditioned medium. We found that at the end of the third washing, there were no [ 14 C]sucrose, arginine, or polyamines in collected DPBS and no [ 14 C]sucrose in cells, indicating little contamination of cell pellets by the medium. To determine whether intracellular arginine might exit from cells during the washing procedure, EC were preloaded with [guanido- 14 C]arginine by incubation in DMEM at 37°C for 2 h and then were used for determining the release of [ 14 C]arginine after the medium was removed, and cells were washed three times with ice-cold DPBS. We found that the cellwashing procedure resulted in the release of 4.3% of intracellular free arginine from EC, indicating that our analysis of arginine in cell lysates only slightly underestimated cellular arginine content.
Uptake of L-arginine by EC. The uptake of L-arginine by transfected EC was measured at 37°C in oxygenated (95% O 2 -5% CO 2 ) Krebs-Henseleit bicarbonate (KHB) buffer containing 20 mM HEPES, 5 mM glucose, 1% BSA, and 0.4 mM 14 C]arginine (0.05 Ci/ml), as previously described (34) . Arginine transport was initiated by addition of cells and terminated in 3 min by addition of 0.2 ml of ice-cold 10 mM L-arginine containing 0.05 Ci D- [2- 3 H]mannitol as an extracellular marker. The solution was mixed immediately and was transferred to a 1.6-ml microcentrifuge tube that contained 0.7 ml of an oil mixture (bromododecane/dodecane, 20:1, vol/vol) overlaid on 0.2 ml of 1.5 M HClO 4 (acid layer). Cells were separated from the medium through the oil layer into the acid layer by centrifugation (10,000 g, 1 min) . The oil layer was washed three times with fresh KHB buffer, and the acid layer was used for the measurement of 3 (32) .
Statistical analysis. Data were analyzed by one-way ANOVA with the Student-Newman-Keuls test for identifying differences among means (27) . P Ͻ 0.05 was taken to indicate statistical significance.
RESULTS
Elevated expression of arginase I and II in EC.
To obtain EC with elevated expression of arginase I or arginase II, cells were stably transfected with expression plasmids containing rat arginase I cDNA or mouse arginase II cDNA. EC stably transfected with the bacterial ␤-galactosidase gene (lacZ) represented the control for expression of an exogenous protein from the elongation factor-1 plasmid. Western blots demonstrated that bovine venular EC transfected with rat arginase I cDNA (AI-EC) or mouse arginase II cDNA (AII-EC) expressed high levels of arginase I or arginase II protein, whereas the low endogenous levels of both arginase isoforms were not detectable by this method in control EC transfected with lacZ (lacZ-EC; Fig. 2 ). Consistent with Western blots, arginase activity was low but measurable in lacZ-EC, averaging 0.43 and 0.21 nmol ⅐ mg protein Ϫ1 ⅐ min Ϫ1 , respectively, in the cytosol and mitochondria and was markedly increased (P Ͻ 0.01) in the cytosol of AI-EC and mitochondria of AII-EC (Fig. 3) . These results reflected the known subcellular localization of arginases I and II in mammalian cells (9, 20, 25) . Arginase specific activity was 258% greater (P Ͻ 0.01) in AI-EC than in AII-EC.
Urea production was elevated (P Ͻ 0.01) by 616% in AI-EC and by 157% in AII-EC compared with lacZ-EC (Fig. 4) . Net production of urea was similar to arginine consumption by EC (P Ͼ 0.05). Net production of ornithine differed markedly (P Ͻ 0.01) among lacZ-EC, AI-EC, and AII-EC and was greatest in AI-EC. Net production of ornithine from arginine was 5, 36, or 12% of net urea production for lacZ-EC, AI-EC, and AII-EC, respectively, reflecting further metabolism of ornithine in these cells.
Effect of elevated arginase expression on NO synthesis. The synthesis of NO (indicated by production of nitrite plus nitrate) was 60 and 47% lower (P Ͻ 0.05) in AI-EC and AII-EC, respectively, compared with lacZ-EC (Fig. 5) . Net production of [ 14 C]citrulline from [ 14 C]arginine (an alternative indicator of NO synthesis) was also markedly reduced (P Ͻ 0.05) in AI-EC and in AII-EC compared with lacZ-EC (Fig. 5) . Because citrulline can be recycled to arginine in EC (7, 33) , the measurement of net [ ]arginine underestimates NO production. By comparing net citrulline production with net nitrite plus nitrate production, the efficiency of recycling citrulline to arginine was calculated to be 60, 80, and 74% in lacZ-EC, AI-EC, and AII-EC, respectively. This calculation represents the upper limit of recycling efficiency because it is based on the simple assumption that NO is produced entirely from exogenous labeled arginine. In reality, some fraction of the arginine used for NO synthesis is probably derived from protein turnover. There were no significant differences (P Ͼ 0.05) in NO synthesis (measured as nitrite ϩ nitrate) or in net citrulline production between AI-EC and AII-EC.
Effect of elevated arginase expression on synthesis of proline and glutamate. These data are summarized in Fig. 6 . Net production of proline from arginine was increased (P Ͻ 0.01) by 928% in AI-EC and by 295% in AII-EC compared with lacZ-EC. Net production of glutamate from arginine was enhanced (P Ͻ 0.01) by 164% in AI-EC and by 79% in AII-EC compared with lacZ-EC. Proline and glutamate syntheses from arginine were greater (P Ͻ 0.01) in AI-EC than in AII-EC. In all EC studied, proline was the major product of arginine catabolism.
Effect of elevated arginase expression on cellular content of arginine, ornithine, and polyamines. Figure 7 shows the cellular content of ornithine and polyamines. Elevated expression of arginase I, but not arginase II, increased (P Ͻ 0.05) cellular content of ornithine by 108% compared with lacZ-EC. Total cellular contents of arginine were 25 and 11% lower (P Ͻ 0.05) in AI-EC and AII-EC, respectively, compared with lacZ-EC (Fig.  5) . Cellular contents of putrescine and spermidine were increased (P Ͻ 0.05) by 275 and 53% in AI-EC and by 158 and 43% in AII-EC, respectively, compared with lacZ-EC. There were no differences (P Ͼ 0.05) in cellular spermine contents among the three groups of EC. There was no detectable accumulation of polyamines in media after a 24-h culture period.
Effect of elevated arginase expression on arginine transport. Arginine transport by AI-EC and AII-EC was 31-33% greater (P Ͻ 0.05) than that by lacZ-EC. The values were 1.26 Ϯ 0.03, 1.24 Ϯ 0.09, and 0.95 Ϯ 0.02 nmol ⅐ mg protein Ϫ1 ⅐ min Ϫ1 (means Ϯ SE; n ϭ 6), respectively, in AI-EC, AII-EC, and lacZ-EC, respectively. There was no difference (P Ͼ 0.05) in arginine uptake between AI-EC and AII-EC.
DISCUSSION
Arginase expression and arginine consumption.
High-level expression of arginase I or arginase II in bovine venular EC was confirmed by Western blot analysis, increased arginase activity, and the appropriate distribution of arginase activity in subcellular fractions of the transfected cells (Figs. 2 and 3) . As a result, arginine consumption was markedly enhanced in EC with elevated expression of arginase I or arginase II (Fig. 4) and was associated with a modest increase in arginine transport via a yet unknown mechanism. As reported previously for rat coronary microvascular EC (34) , net production of urea in bovine EC closely matched arginine consumption, indicating that utilization of arginine by arginase was far greater than its utilization for synthesis of NO or proteins.
Ornithine is a coproduct of arginase. However, the ornithine accumulated at the end of a 24-h culture period does not represent total production of ornithine from arginine, as ornithine can be further metabolized to proline and glutamate (Fig. 6) as well as to CO 2 (34) . Interestingly, net production of ornithine, expressed as a percentage of net urea formation, increased in direct proportion to cellular arginase activity, suggesting that OAT is a limiting factor for endothelial ornithine metabolism when arginase activity is enhanced. Arginase expression and NO synthesis. Both arginase and NOS utilize arginine as substrate, thus raising the question of whether these two enzymes directly compete for intracellular arginine (36) . Such an interplay between arginase and NOS is particularly complex in the case of EC, because these cells contain both cytosolic arginase I and mitochondrial arginase II (2). Further complicating this picture is the fact that eNOS is located in both the membrane-bound caveolae and the cytoplasm (11, 16) , and thus it is not known whether arginase I and II may differentially modulate NO production by EC. The cloning of arginase I and II cDNAs (10, 20, 25) has provided a useful tool to study the potential roles of arginase isoforms in regulating endothelial NO synthesis.
Results of this study demonstrate that increased expression of arginase I or arginase II markedly reduced basal NO synthesis in EC (Fig. 5) . The reductions in NO synthesis suggested a possible depletion of intracellular arginine in AI-EC and A-II EC, and this was consistent with modest but significant decreases in intracellular arginine content in these cells (Fig. 5) . On the basis of cell volume (0.462 l/10 6 cells) and protein content (268 g/10 6 cells) in bovine coronary venular EC (14) and HPLC analysis of cellular arginine (expressed as nmol/mg protein; Fig. 5 ), intracellular arginine concentrations in lacZ-EC, AI-EC, and AII-EC were calculated to be 2.16 Ϯ 0.04, 1.61 Ϯ 0.08, and 1.92 Ϯ 0.05 mM (means Ϯ SE; n ϭ 6), respectively. These values are similar to those (1-2 mM) previously reported for freshly isolated EC or EC cultured in the presence of 0.4 mM arginine (36) and are substantially higher than the Michaelis-Menten value (2.9 M) of purified eNOS for L-arginine (11) . Consequently, the declines in NO synthesis could not be accounted for by the declines in intracellular arginine concentration. These results suggest that a distinct intracellular pool of arginine available for NO synthesis exists that was more depleted than indicated by the decrease in total intracellular arginine content. Thus the apparent arginine paradox in endothelial NO synthesis remains to be fully explained (35) .
Arginase I may be colocalized or closely associated with eNOS such that high-level expression of arginase I may reduce arginine concentrations at or near the site of NO production. However, it is not clear how arginase II (a mitochondrial enzyme) might compete with eNOS for intracellular arginine. A possible explanation for this interplay is that an increase in mitochondrial arginine degradation by arginase II may result in enhanced transport of arginine from the cytosol into mitochondria, thereby reducing the availability of cytosolic arginine for NO synthesis. Interestingly, Gotoh and Mori (5) also found that elevated expression of arginase II reduced NO production by iNOS in activated RAW 264.7 murine macrophages.
Bovine and human EC can synthesize arginine from citrulline (7, 33) , as macrophages and smooth muscle cells (19, 31) . On the basis of the production of nitrite plus nitrate vs. the net accumulation of citrulline, the efficiency of citrulline-to-arginine recycling was calculated to be 60, 80, and 74% in lacZ-EC, AI-EC, and AII-EC, respectively. Thus activities of the argininesynthetic enzymes in bovine venular EC were not sufficient to completely recycle citrulline to arginine, even at the low basal rate of NO synthesis. Results from the bovine venular EC contrast with the apparent lack of such recycling in rat coronary microvascular EC (34), indicating species or anatomical differences in the ability of EC for this recycling.
Arginase expression and production of proline, glutamate, and polyamines. Ornithine is the common substrate for the synthesis of proline, glutamate, and polyamines in mammalian cells (Fig. 1) . OAT (a mitochondrial enzyme) converts ornithine into pyrroline-5-carboxylate (P5C), which is subsequently converted to glutamate by P5C dehydrogenase (a mitochondrial enzyme) or to proline by P5C reductase (a cytosolic enzyme; see Ref. 36) . Elevated expression of arginase I or arginase II increased the production of both proline and glutamate from arginine by EC, indicating that these synthetic pathways in EC normally are limited by availability of the substrate ornithine. Thus ornithine generated in either the cytosol or mitochondria is available for conversion to P5C by mitochondrial OAT. Net production of proline was greater than that of glutamate in all EC studied. This may be explained by our finding that P5C reductase activity was much greater than P5C dehydrogenase activity in EC (Wu and Meininger, unpublished data) and by the fact that glutamate can readily participate in transamination reactions. Proline is a major amino acid for the synthesis of collagen and the generation of extracellular matrix, and thus an increase in proline synthesis from arginine may play an important role in vascular remodeling.
ODC is the first and rate-controlling enzyme in polyamine synthesis from ornithine (36) . Because ODC and arginase I are colocalized in the cytosol, the ornithine generated by arginase I is readily utilized for polyamine synthesis (10a, 22) . However, the role of arginase II in polyamine synthesis is unknown. On the basis of our recent finding that mitochondrially generated ornithine can serve as a substrate for cytosolic polyamine synthesis in enterocytes (32), we anticipated that an increase in ornithine production by arginase II would stimulate polyamine synthesis in EC. Results of the current study demonstrate that elevated expression of arginase I or arginase II did enhance the cellular content of putrescine and spermidine in EC (Fig. 7) , indicating an increase in their synthesis from arginine. Similarly, we also found that elevated expression of arginase I stimulated the synthesis of putrescine and spermidine in activated macrophages (10a, 22) . Because polyamines are essential to EC proliferation (23), enhanced synthesis of polyamines from arginine may play an important role in angiogenesis and wound healing. In this regard, it is noteworthy that arginase activity is severely deficient in EC of the diabetic BB rat (an animal model of human type I diabetes mellitus; see Ref. 34) , and these cells exhibit a marked impairment in proliferation (15) . Elevating expression of arginase I or arginase II in diabetic EC may provide a novel gene therapy for improving angiogenesis and wound healing in diabetes mellitus.
In conclusion, our results demonstrate for the first time that increased expression of arginase I or arginase II reduced NO synthesis, promoted the production of glutamate and proline, and enhanced cellular polyamine content in EC. Because of the significant metabolic changes that occur when expression of either arginase is enhanced, we conclude that arginase normally is a limiting or regulatory factor in venular EC arginine metabolism. Because EC play an essential role in regulating vascular tone and angiogenesis, physiological or pathophysiological variations in expression of the arginase isoforms in EC may have important implications for cardiovascular function in health and disease.
